Olfactive Biosolutions, which is adapting food molecules to treat chronic diseases, has secured a third US patent covering a novel method for stimulating the production of GLP-1 and GIP (gastric inhibitory polypeptide), hormones crucial for regulating blood sugar. Poised as an alternative therapy for diabetes and obesity, it is based on natural food molecules that activate smell and taste receptors found across the body.With its proprietary formulations based on “cheap and plentiful” food molecules, the company intends to replace conventional weight management pharmaceuticals globally. Unlike some medicines, they come without side effects and can be consumed on a long-term basis.
